Martingale Asset Management’s Entrada Therapeutics TRDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $265K | Sell |
39,463
-700
| -2% | -$4.7K | 0.01% | 723 |
|
|
2025
Q1 | $363K | Buy |
40,163
+1,540
| +4% | +$13.9K | 0.01% | 651 |
|
|
2024
Q4 | $668K | Buy |
38,623
+700
| +2% | +$12.1K | 0.02% | 557 |
|
|
2024
Q3 | $606K | Buy |
37,923
+10,226
| +37% | +$163K | 0.01% | 590 |
|
|
2024
Q2 | $395K | Buy |
27,697
+9,245
| +50% | +$132K | 0.01% | 651 |
|
|
2024
Q1 | $261K | Buy |
+18,452
| New | +$261K | 0.01% | 728 |
|